Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers

PHASE1UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 20, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

July 31, 2021

Conditions

Healthy

Interventions

DRUG

Normal saline

100ml

DRUG

DWJ1521

Single dose

DRUG

DWP14012 Tablet

Single dose, Tablet

Trial Locations (1)

RECRUITING

Seoul National University Hospital, Seoul